Skip to main content

Advertisement

Log in

Should total omentectomy be performed for advanced gastric cancer?: The role of omentectomy during laparoscopic gastrectomy for advanced gastric cancer

  • 2021 SAGES Oral
  • Published:
Surgical Endoscopy Aims and scope Submit manuscript

Abstract

Background

In the era of minimally invasive surgery, laparoscopic partial omentectomy (LPO) has seen widespread use as a curative surgical procedure for early gastric cancer. However, scientific evidence of the extent of omentectomy during laparoscopic gastrectomy remains unclear for advanced gastric cancer (AGC).

Methods

We analyzed 666 eligible patients who underwent laparoscopic gastrectomy for AGC with curative intent between 2014 and 2018. Surgical outcome and postoperative prognosis were compared between LPO and laparoscopic total omentectomy (LTO) groups after 2:1 propensity score matching with age, sex, body mass index, tumor size, pT stage, pN stage, gastrectomy type, and clinical T stage as covariates.

Results

After extensive matching, there was no significant difference in pathologic or clinical stages between the LPO (n = 254) and LTO (n = 177) groups. LPO provided a significantly shorter operation time than LTO (199.2 ± 64.8 vs. 248.1 ± 68.3 min, P < 0.001). Pulmonary complication within postoperative 30 days was significantly lower in the LPO group (4.4 vs. 10.3%, P = 0.018). In multivariate analysis, LTO was the independent risk factor for pulmonary complication (odds ratio [OR] 2.53, 95% confidence interval [95% CI] 1.12–5.73, P = 0.025), which became more obvious in patients with a Charlson’s comorbidity index of 4 or higher (OR 27.43, 95% CI 1.35–558.34, P = 0.031). The 5-year overall survival rate (OS) and 3-year recurrence-free survival (RFS) rates were not significantly different between the two groups, even after stage stratification.

Conclusion

LPO provided significantly shorter operation time and less pulmonary complication than LTO without compromising 5-year OS and 3-year RFS for AGC. LTO was the independent risk factor for pulmonary complications, which became more evident in patients with severe comorbidities.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. Groves EH (1910) The radical operation for cancer of the pylorus, with especial reference to the advantages of the two-stage operation and to the question of the removal of the associated lymphatics. Proc R Soc Med 3:117–164

    CAS  PubMed  PubMed Central  Google Scholar 

  2. Japanese Gastric Cancer Association (2021) Japanese gastric cancer treatment guidelines 2018 (5th edition). Gastric Cancer 24(1):1–21. https://doi.org/10.1007/s10120-020-01042-y

    Article  Google Scholar 

  3. National Comprehensive Cancer Network (NCCN) (2019) NCCN clinical practice guidelines in oncology. Gastric Cancer Version5

  4. Kim HH, Han SU, Kim MC, Kim W, Lee HJ, Ryu SW, Cho GS, Kim CY, Yang HK, Park DJ, Song KY, Lee SI, Ryu SY, Lee JH, Hyung WJ, Korean Laparoendoscopic Gastrointestinal Surgery Study (KLASS) Group (2019) Effect of laparoscopic distal gastrectomy vs open distal gastrectomy on long-term survival among patients with stage I gastric cancer: the KLASS-01 randomized clinical trial. JAMA Oncol 5(4):506–513

    Article  Google Scholar 

  5. Kim W, Kim HH, Han SU, Kim MC, Hyung WJ, Ryu SW, Cho GS, Kim CY, Yang HK, Park DJ, Song KY, Lee SI, Ryu SY, Lee JH, Lee HJ, Korean Laparo-endoscopic Gastrointestinal Surgery Study (KLASS) Group (2016) Decreased morbidity of laparoscopic distal gastrectomy compared with open distal gastrectomy for stage I gastric cancer: short-term outcomes from a multicenter randomized controlled trial (KLASS-01). Ann Surg 263(1):28–35

    Article  Google Scholar 

  6. Hyung WJ, Yang HK, Park YK, Lee HJ, An JY, Kim W, Kim HI, Kim HH, Ryu SW, Hur H, Kim MC, Kong SH, Cho GS, Kim JJ, Park DJ, Ryu KW, Kim YW, Kim JW, Lee JH, Han SU, Korean Laparoendoscopic Gastrointestinal Surgery Study Group (2020) Long-term outcomes of laparoscopic distal gastrectomy for locally advanced gastric cancer: the KLASS-02-RCT randomized clinical trial. J Clin Oncol 38(28):3304–3313

    Article  Google Scholar 

  7. Yu J, Huang C, Sun Y, Su X, Cao H, Hu J, Wang K, Suo J, Tao K, He X, Wei H, Ying M, Hu W, Du X, Hu Y, Liu H, Zheng C, Li P, Xie J, Liu F, Li Z, Zhao G, Yang K, Liu C, Li H, Chen P, Ji J, Li G, Chinese Laparoscopic Gastrointestinal Surgery Study (CLASS) Group (2019) Effect of laparoscopic vs open distal gastrectomy on 3-year disease-free survival in patients with locally advanced gastric cancer: the CLASS-01 randomized clinical trial. JAMA 321(20):1983–1992

    Article  Google Scholar 

  8. Murakami H, Yamada T, Taguri M, Hasegawa S, Yamanaka T, Rino Y, Mushiake H, Oshima T, Matsukawa H, Tani K, Suzuki Y, Ozawa Y, Tanabe H, Osaragi T, Sato T, Tamagawa H, Yukawa N, Yoshikawa T, Imada T, Masuda M, Yamamoto Y (2021) Short-term outcomes from a randomized screening phase II non-inferiority trial comparing omentectomy and omentum preservation for locally advanced gastric cancer: the TOP-G trial. World J Surg 45(6):1803–1811

    Article  Google Scholar 

  9. Park DJ, Han SU, Hyung WJ, Kim MC, Kim W, Ryu SY, Ryu SW, Song KY, Lee HJ, Cho GS, Kim HH, Korean Laparoscopic Gastrointestinal Surgery Study (KLASS) Group (2012) Long-term outcomes after laparoscopy-assisted gastrectomy for advanced gastric cancer: a large-scale multicenter retrospective study. Surg Endosc 26(6):1548–1553

    Article  Google Scholar 

  10. Sakimura Y, Inaki N, Tsuji T, Kadoya S, Bando H (2020) Long-term outcomes of omentum-preserving versus resecting gastrectomy for locally advanced gastric cancer with propensity score analysis. Sci Rep 10(1):16305

    Article  CAS  Google Scholar 

  11. Amin MB, Greene FL, Edge SB, Compton CC, Gershenwald JE, Brookland RK, Meyer L, Gress DM, Byrd DR, Winchester DP (2017) The Eighth Edition AJCC Cancer Staging Manual: continuing to build a bridge from a population-based to a more “personalized” approach to cancer staging. CA Cancer J Clin 67(2):93–99

    Article  Google Scholar 

  12. Charlson M, Szatrowski TP, Peterson J, Gold J (1994) Validation of a combined comorbidity index. J Clin Epidemiol 47(11):1245–1251

    Article  CAS  Google Scholar 

  13. World Health Organization (2000) Regional Office for the Western P. The Asia-Pacific perspective: redefining obesity and its treatment. Health Communications Australia, Sydney

    Google Scholar 

  14. Dindo D, Demartines N, Clavien PA (2004) Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg 240(2):205–213

    Article  Google Scholar 

  15. Slankamenac K, Graf R, Barkun J, Puhan MA, Clavien PA (2013) The comprehensive complication index: a novel continuous scale to measure surgical morbidity. Ann Surg 258(1):1–7

    Article  Google Scholar 

  16. Molena D, Mungo B, Stem M, Lidor AO (2014) Incidence and risk factors for respiratory complications in patients undergoing esophagectomy for malignancy: a NSQIP analysis. Semin Thorac Cardiovasc Surg 26(4):287–294

    Article  Google Scholar 

  17. Miskovic A, Lumb AB (2017) Postoperative pulmonary complications. Br J Anaesth 118(3):317–334

    Article  CAS  Google Scholar 

  18. Howell AC, Gould DJ, Mayfield C, Samakar K, Hassani C, Patel KM (2018) Anatomical basis of the gastroepiploic vascularized lymph node transfer: a radiographic evaluation using computed tomographic angiography. Plast Reconstr Surg 142(4):1046–1052

    Article  CAS  Google Scholar 

  19. Bazigou E, Wilson JT, Moore JE Jr. (2014) Primary and secondary lymphatic valve development: molecular, functional and mechanical insights. Microvasc Res 96:38–45

    Article  Google Scholar 

  20. Fujitani K, Yang HK, Kurokawa Y, Park DJ, Tsujinaka T, Park BJ, Fukuda H, Noh SH, Boku N, Bang YJ, Sasako M, Lee JI, Gastric Cancer Surgical Study Group of Japan Clinical Oncology Group; Korea Gastric Cancer Association (2008) Randomized controlled trial comparing gastrectomy plus chemotherapy with chemotherapy alone in advanced gastric cancer with a single non-curable factor: Japan Clinical Oncology Group Study JCOG 0705 and Korea Gastric Cancer Association Study KGCA01. Jpn J Clin Oncol. 38(7):504–506

    Article  Google Scholar 

Download references

Funding

This work has supported by the National Research Foundation of Korea(NRF) grant funded by the Korea government(MSIT) (No. 2020R1C1C100922512). This research was supported by Research Program 2020 funded by Seoul National University College of Medicine Research Foundation (800-20200345).

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Yun-Suhk Suh.

Ethics declarations

Disclosures

Sangjun Lee, MD, So Hyun Kang, MD, Yongjoon Won, MD, Young Suk Park, MD, Sang-Hoon Ahn, MD, and Hyung-Ho Kim, MD, PhD have no conflicts of interest or financial ties to disclose.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary Information

Below is the link to the electronic supplementary material.

Supplementary file1 (DOCX 792 kb)

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Lee, S., Suh, YS., Kang, S.H. et al. Should total omentectomy be performed for advanced gastric cancer?: The role of omentectomy during laparoscopic gastrectomy for advanced gastric cancer. Surg Endosc 36, 6937–6948 (2022). https://doi.org/10.1007/s00464-022-09039-7

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00464-022-09039-7

Keywords

Navigation